Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption-Reference-Cited by-同舟云学术

Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption

Published:2016-11-19 Issue:51 Volume:7 Page:85515-85528
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhao Haijun¹²,Shi Pengcheng¹,Deng Manman³,Jiang Zhiwu⁴,Li Yin¹,Kannappan Vinodh⁵,Wang Weiguang⁵,Li Peng⁴,Xu Bing¹³

Affiliation:

1. Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China

2. Department of Hematology, Anqing Municipal Hospital of Anhui Medical University, Anqing, P. R. China

3. Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, P. R. China

4. Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, P. R. China

5. Research Institute in Healthcare Science, Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of (R)-4-(8-methoxy-2-methyl-1-(1-phenylethy)-1H-imidazo[4,5-c]quinnolin-7-yl)-3,5-dimethylisoxazole as a potent and selective BET inhibitor for treatment of acute myeloid leukemia (AML) guided by FEP calculation;European Journal of Medicinal Chemistry;2024-01

2. The roles of TPL in hematological malignancies;Hematology;2023-07-04

3. Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway;Journal of Chemotherapy;2022-06-06

4. Long non‑coding RNA MIR17HG sponges microRNA‑21 to upregulate PTEN and regulate homoharringtonine‑based chemoresistance of acute myeloid leukemia cells;Oncology Letters;2021-11-18

5. Redox Control in Acute Lymphoblastic Leukemia: From Physiology to Pathology and Therapeutic Opportunities;Cells;2021-05-17